EGFR antisense DNA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR antisense DNA, covering 2017-02-15 to 2017-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma [Phase 1]